Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.4 - $1.39 $175 - $608
438 Added 0.08%
566,176 $277,000
Q2 2023

Aug 11, 2023

BUY
$1.07 - $1.55 $242,947 - $351,933
227,054 Added 67.04%
565,738 $707,000
Q1 2023

May 15, 2023

BUY
$0.42 - $1.4 $29,179 - $97,266
69,476 Added 25.81%
338,684 $386,000
Q4 2022

Feb 13, 2023

BUY
$0.31 - $0.58 $5,085 - $9,514
16,405 Added 6.49%
269,208 $113,000
Q2 2022

Aug 12, 2022

SELL
$0.63 - $1.22 $271 - $525
-431 Reduced 0.17%
252,803 $166,000
Q1 2022

May 13, 2022

SELL
$0.99 - $2.44 $0 - $2
-1 Reduced -0.0%
253,234 $291,000
Q4 2021

Feb 11, 2022

SELL
$2.18 - $3.93 $3,516 - $6,339
-1,613 Reduced 0.63%
253,235 $564,000
Q3 2021

Nov 12, 2021

BUY
$2.71 - $4.35 $48,625 - $78,052
17,943 Added 7.57%
254,848 $759,000
Q2 2021

Aug 13, 2021

SELL
$2.94 - $4.75 $436,360 - $705,004
-148,422 Reduced 38.52%
236,905 $914,000
Q1 2021

May 12, 2021

BUY
$3.99 - $5.53 $276,155 - $382,742
69,212 Added 21.89%
385,327 $1.66 Million
Q4 2020

Feb 12, 2021

SELL
$2.99 - $5.79 $45,406 - $87,926
-15,186 Reduced 4.58%
316,115 $1.23 Million
Q3 2020

Nov 13, 2020

BUY
$4.79 - $9.1 $119,601 - $227,217
24,969 Added 8.15%
331,301 $1.63 Million
Q2 2020

Aug 13, 2020

BUY
$3.61 - $11.84 $292,460 - $959,205
81,014 Added 35.96%
306,332 $2.21 Million
Q1 2020

May 14, 2020

BUY
$2.56 - $6.14 $60,085 - $144,111
23,471 Added 11.63%
225,318 $944,000
Q4 2019

Feb 13, 2020

BUY
$5.78 - $8.11 $10,467 - $14,687
1,811 Added 0.91%
201,847 $1.19 Million
Q3 2019

Nov 12, 2019

BUY
$6.55 - $9.36 $75,213 - $107,480
11,483 Added 6.09%
200,036 $1.65 Million
Q2 2019

Aug 14, 2019

BUY
$5.92 - $9.47 $1.12 Million - $1.79 Million
188,553 New
188,553 $1.77 Million

Others Institutions Holding BSGM

About BioSig Technologies, Inc.


  • Ticker BSGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,814,400
  • Market Cap $15.7M
  • Description
  • BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...
More about BSGM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.